In a study conducted for primary breast cancer, 77 (18.0%) of 427 primary breast cancer patients were found to have EMT-CTCs characterized by TWIST, SNAIL1, SLUG, and ZEB1 expression levels, and patients without EMT-CTCs had a longer disease-free survival than those with EMT-CTCs [53]. The gene discussed is SNAI2; the disease is breast carcinoma.